Citation Impact
Citing Papers
The human disease network
2007 Standout
Characterization of a canine homolog of hepatitis C virus
2011 StandoutNobel
Jinx , an MCMV susceptibility phenotype caused by disruption of Unc13d : a mouse model of type 3 familial hemophagocytic lymphohistiocytosis
2007 StandoutNobel
The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS)
2009
Chronic Kidney Disease and Albuminuria in Children with Sickle Cell Disease
2011
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
2019 StandoutNobel
Haemodynamic definitions and updated clinical classification of pulmonary hypertension
2018 Standout
Long-Term Outcome and Evaluation of Organ Function in Pediatric Patients Undergoing Haploidentical and Matched Related Hematopoietic Cell Transplantation for Sickle Cell Disease
2013
Management of Sickle Cell Disease
2014
Survival among children and adults with sickle cell disease in Belgium: Benefit from hydroxyurea treatment
2015
Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism.
1993
Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections
2005 StandoutNatureNobel
Hyperhomocysteinaemia
1999
Sequence and exon-intron organization of the DNA encoding the alpha I domain of human spectrin. Application to the study of mutations causing hereditary elliptocytosis.
1989 StandoutNobel
Hemoglobin disorders and endothelial cell interactions
2009
Mechanisms of Thrombus Formation
2008 Standout
Review: Hemodynamic Characteristics and Outcomes of Sickle Cell Disease Associated Pulmonary Hypertension
2016
Pulmonary hypertension in sickle cell disease
2015
Haemoglobinopathies and the rheumatologist
2016
Erythroid adhesion molecules in sickle cell disease: Effect of hydroxyurea
2008
Mortality in Adults With Sickle Cell Disease and Pulmonary Hypertension
2012
Hypoxia Activates a Ca2+-Permeable Cation Conductance Sensitive to Carbon Monoxide and to GsMTx-4 in Human and Mouse Sickle Erythrocytes
2010
The β-Thalassemias
1999 Standout
Cardiovascular complications and risk of death in sickle-cell disease
2016
Evidence review of hydroxyurea for the prevention of sickle cell complications in low-income countries
2013
Molecular analysis of insertion/deletion mutations in protein 4.1 in elliptocytosis. I. Biochemical identification of rearrangements in the spectrin/actin binding domain and functional characterizations.
1990 StandoutNobel
Management of Patients with Sickle Cell Disease Using Transfusion Therapy
2016
Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
2002 Standout
Pathogenesis of human parvovirus B19 in rheumatic disease
2000
Pediatric Pulmonary Hypertension
2013
Hydroxyurea for sickle cell disease in children and for prevention of cerebrovascular events: the Belgian experience
2004
Hepatitis C Virus in the HIV-Infected Patient
2006
GB virus type C interactions with HIV: the role of envelope glycoproteins
2009
Hydroxyurea Therapy for Pediatric Patients With Hemoglobin SC Disease
2001
1 The population genetics of the haemoglobinopathies
1998
Infection in sickle cell disease: A review
2009
Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria
2006 StandoutNobel
2 B19 parvovirus
1995
Molecular analysis of insertion/deletion mutations in protein 4.1 in elliptocytosis. II. Determination of molecular genetic origins of rearrangements.
1990 StandoutNobel
Modifier genes and sickle cell anemia
2006
Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection
1996 Standout
PERSPECTIVE ARTICLE: Growth factors and cytokines in wound healing
2008 Standout
Genetic modifiers of sickle cell disease
2012
Iron status and the outcome of HIV infection: an overview
2001
Clinical management of adult sickle-cell disease
2012
Early detection of pulmonary arterial hypertension
2014
Sickle Hemoglobin Confers Tolerance to Plasmodium Infection
2011
PARVOVIRUS B19 INFECTION IN PEDIATRIC TRANSPLANT PATIENTS
1993
Dehydrated hereditary stomatocytosis linked to gain-of-function mutations in mechanically activated PIEZO1 ion channels
2013 StandoutNobel
Reconstituted and native iron-cores of bacterioferritin and ferritin
1987
Two to Tango: Regulation of Mammalian Iron Metabolism
2010 Standout
Platelet Activation and Atherothrombosis
2007 Standout
Cardiomyopathy With Restrictive Physiology in Sickle Cell Disease
2016
OVERWHELMING POSTSPLENECTOMY INFECTION
1996
Sickle cell disease: renal manifestations and mechanisms
2015
Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy
2004
Differential control of band 3 lateral and rotational mobility in intact red cells.
1994 StandoutNobel
Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients.
1994
8 The population genetics of the haemoglobinopathies
1993
Human Parvo Virus B19 Infection among Hospital Staff Members after Contact with Infected Patients
1989
Heparin-Induced Thrombocytopenia
2006 Standout
Reconstructing sickle cell disease: A data‐based analysis of the “hyperhemolysis paradigm” for pulmonary hypertension from the perspective of evidence‐based medicine
2010
Investigational drugs in sickle cell anemia
2009
Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle
1990 Nature
Analysis of a Successful Immune Response against Hepatitis C Virus
1999 StandoutNobel
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Viral-associated haemophagocytosis with parvovirus-B19-related pancytopenia
1992
Stroke in Children With Sickle Cell Anaemia
2001
Microvesicles in haemoglobinopathies offer insights into mechanisms of hypercoagulability, haemolysis and the effects of therapy
2008
Sickle cell disease: no longer a single gene disorder
2001
Sickle-cell disease
2010 Standout
A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor
1993 Standout
HIV as the cause of AIDS
1996 StandoutNobel
Deconstructing sickle cell disease: Reappraisal of the role of hemolysis in the development of clinical subphenotypes
2006
Antithrombotic Therapy in Neonates and Children
2008
Clinical and hematologic effects of hydroxyurea in children with sickle cell anemia
1996
Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages
2007 StandoutNobel
Longitudinal monitoring of bone mineral density in thalassemic patients. Genetic structure and osteoporosis
1997
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
5 Thalassaemia: clinical management
1998
Parvovirus B19 for the hematologist
1992
Erythema infectiosum (fifth disease) occurrence in Iowa.
1988
Sickle cell disease in Africa: burden and research priorities
2007
Pulmonary Complications of Sickle Cell Disease
2008
Disorders of Iron Metabolism
1999 Standout
Sickle cell disease in Africa
2002
Long-term hydroxyurea treatment in young sickle cell patients
1999
B19 parvovirus DNA in solvent/detergent-treated anti-haemophilia concentrates
1994
Effect of Hydroxyurea Therapy on Resting Energy Expenditure in Children With Sickle Cell Disease
2001
Thrombogenesis in sickle cell disease
2001
Linkage of Dominant Hereditary Spherocytosis to the Gene for the Erythrocyte Membrane-Skeleton Protein Ankyrin
1990 StandoutNobel
Sickle cell disease and the kidney
2008
A Putative Src Homology 3 Domain Binding Motif but Not the C-terminal Dystrophin WW Domain Binding Motif Is Required for Dystroglycan Function in Cellular Polarity in Drosophila
2007 StandoutNobel
Red cell indices in classification and treatment of anemias
2013
Moyamoya Disease and Moyamoya Syndrome
2009 Standout
Homocysteine and Atherothrombosis
1998 Standout
Parvovirus B19
2004 Standout
Pharmacologic Modulation of Fetal Hemoglobin
2001
Anemia of Chronic Disease
2005 Standout
Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC
2015
Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantation
2009 Standout
Chronic and acute anemia and extracranial internal carotid stenosis are risk factors for silent cerebral infarcts in sickle cell anemia
2014
Pulmonary Complications of Sickle Cell Disease
2012
Extracellular DNA traps promote thrombosis
2010 Standout
Analysis of Hepatitis C Virus-Inoculated Chimpanzees Reveals Unexpected Clinical Profiles
1998
Biochemical surrogate markers of hemolysis do not correlate with directly measured erythrocyte survival in sickle cell anemia
2016
The spleen and sickle cell disease: the sick(led) spleen
2014
HIV Population Dynamics in Vivo: Implications for Genetic Variation, Pathogenesis, and Therapy
1995 StandoutScience
Predictors of fetal hemoglobin response in children with sickle cell anemia receiving hydroxyurea therapy
2002
Hereditary elliptocytosis, spherocytosis and related disorders: Consequences of a deficiency or a mutation of membrane skeletal proteins
1987
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
2015 Standout
Red cell membrane sialoglycoptein β in homozygous and heterozygous 4.1(−) hereditary elliptocytosis
1985
Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy
2005
Hemostatic Alterations in Sickle Cell Disease: Relationships to Disease Pathophysiology
2001
Distinct HLA associations by stroke subtype in children with sickle cell anemia
2003
Molecular recognition in biomineralization
1988 StandoutNature
Structural and Functional Aspects of Metal Sites in Biology
1996 Standout
Human Parvovirus B19
2002 Standout
Hydroxyurea for Sickle Cell Disease: A Systematic Review for Efficacy and Toxicity in Children
2008
Spectrin beta-chain variant associated with hereditary elliptocytosis.
1982
Use of dried blood spot specimens in the detection of human immunodeficiency virus type 1 by the polymerase chain reaction
1991
Hereditary Elliptocytosis and Related Disorders
1985
Alteration of the erythrocyte membrane skeletal ultrastructure in hereditary spherocytosis, hereditary elliptocytosis, and pyropoikilocytosis
1990 StandoutNobel
A Heme Export Protein Is Required for Red Blood Cell Differentiation and Iron Homeostasis
2008 Science
Homocysteine and Thrombotic Disease
1997
Pulmonary hypertension and nitric oxide depletion in sickle cell disease
2010
Prevalence and Risk Factors for Pulmonary Arterial Hypertension in a Large Group of β-Thalassemia Patients Using Right Heart Catheterization
2013
Dissecting Human Disease in the Postgenomic Era
2001 Science
Mutant forms of spectrin alpha-subunits in hereditary elliptocytosis.
1987 StandoutNobel
Double inheritance of an alpha I/65 spectrin variant in a child with homozygous elliptocytosis
1986
A molecular study of heterozygous protein 4.1 deficiency in hereditary elliptocytosis
1988
Severe Anemia Caused by Human Parvovirus in a Leukemia Patient on Maintenance Chemotherapy
1988
Disease Tolerance as a Defense Strategy
2012 StandoutScience
Haemoglobinuria is associated with chronic kidney disease and its progression in patients with sickle cell anaemia
2013
Sickle cell disease and stroke
2009
The ethics of a proposed study of hematopoietic stem cell transplant for children with “less severe” sickle cell disease
2014
Evidence for HLA-related susceptibility for stroke in children with sickle cell disease
2000
Pathogenesis of human immunodeficiency virus infection
1993
Hydroxyurea as an Alternative to Blood Transfusions for the Prevention of Recurrent Stroke in Children With Sickle Cell Disease
1999
Estimated pulmonary artery systolic pressure and sickle cell disease: a meta‐analysis and systematic review
2015
Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease.
1999
Dendritic cell maturation by innate lymphocytes
2005 StandoutNobel
Six Months of Hydroxyurea Reduces Albuminuria in Patients with Sickle Cell Disease
2015
Whole Blood Tissue Factor Procoagulant Activity Is Elevated in Patients With Sickle Cell Disease
1998
Pathophysiology and treatment of pulmonary hypertension in sickle cell disease
2016
Identification of the hereditary pyropoikilocytosis carrier state
1984
A structural model of human erythrocyte protein 4.1.
1984
Transfusion therapy for sickle cell disease: a balancing act
2013
Five years of experience with hydroxyurea in children and young adults with sickle cell disease
2001
Iron-Deficiency Anemia
2015 Standout
Molecular biology of the Rh antigens
1991 StandoutNobel
Distinct variants of erythrocyte protein 4.1 inherited in linkage with elliptocytosis and Rh type in three white families
1988 StandoutNobel
Factors associated with survival in a contemporary adult sickle cell disease cohort
2014
How I manage cerebral vasculopathy in children with sickle cell disease
2015
Hydroxyurea corrects the dysregulated L-selectin expression and increased H2O2 production of polymorphonuclear neutrophils from patients with sickle cell anemia
2002
A new abnormal variant of spectrin in black patients with hereditary elliptocytosis
1985
Thrombophilia in sickle cell disease: the red cell connection
2001
The contribution of hypogonadism to the development of osteoporosis in thalassaemia major: new therapeutic approaches
1995
Molecular Basis of Hereditary Elliptocytosis Due to Protein 4.1 Deficiency
1986
Density-based separation in multiphase systems provides a simple method to identify sickle cell disease
2014
RHEUMATIC MANIFESTATIONS OF PARVOVIRUS B19 INFECTION
1998
CD1: Antigen Presentation and T Cell Function
2004
Iron-Chelating Therapy and the Treatment of Thalassemia
1997
Declining stroke rates in Californian children with sickle cell disease
2004
Sustained expansion of NKT cells and antigen-specific T cells after injection of α-galactosyl-ceramide loaded mature dendritic cells in cancer patients
2005 StandoutNobel
Systematic Review: Hydroxyurea for the Treatment of Adults with Sickle Cell Disease
2008
Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group.
1999
Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society.
1991
Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease
2003
Treatment of Cooley's anemia [see comments]
1990
Spα1/65 hereditary elliptocytosis in North Africa
1986
Long-term hydroxyurea treatment in children with sickle cell disease: tolerance and clinical outcomes.
2006
The heterozygous form of 4.1(-) hereditary elliptocytosis [the 4.1(-) trait]
1985
Works of Robert Girot being referenced
Three-Year Follow-Up of Hydroxyurea Treatment in Severely Ill Children with Sickle Cell Disease
1997
Normal Growth Hormone (GH) Response to GHReleasing Hormone in Children with Thalassemia Major Before Puberty: A Possible Age-Related Effect
1989
Hemoglobin sickle cell disease complications: a clinical study of 179 cases
2012
The relative importance of the X‐linked FCP locus and β‐globin haplotypes in determining haemoglobin F levels: a study of SS patients homozygous for βS haplotypes
1997
High lactate dehydrogenase levels at admission for painful vaso-occlusive crisis is associated with severe outcome in adult SCD patients
2012
Dose of desferrioxamine and evolution of HIV‐1 infection in thalassaemic patients
1994
Full or Partial Seroreversion in Patients Infected by Hepatitis C Virus
1997
A Hemodynamic Study of Pulmonary Hypertension in Sickle Cell Disease
2011
DNA haplotype distribution in Algerian ? thalassaemia patients
1988
Clinical Follow-Up of Hydroxyurea-Treated Adults with Sickle Cell Disease
2010
Topical Effectiveness of Molgramostim (GM-CSF) in Sickle Cell Leg Ulcers
2004
Influence of sickle cell disease and treatment with hydroxyurea on sperm parameters and fertility of human males
2008
Analysis of the red cell membrane in a family with hereditary elliptocytosis — total or partial of protein 4.1
1981
Deep vein thrombosis during enoxaparin prophylactic treatment in a young pregnant woman homozygous for factor V Leiden and heterozygous for the G127 ← A mutation in the thrombomodulin gene
2000
Endothelin receptor antagonism prevents hypoxia-induced mortality and morbidity in a mouse model of sickle-cell disease
2008
Urinary endothelin-1 as a marker of renal damage in sickle cell disease
2005
DNA amplification of HIV-1 in seropositive individuals and in seronegative at-risk individuals
1990
Sickle cell leg ulcers: a frequently disabling complication and a marker of severity
2007
Strong association between a new marker of hemolysis and glomerulopathy in sickle cell anemia
2010
Prevalence and Correlates of Metabolic Acidosis among Patients with Homozygous Sickle Cell Disease
2014
Maternal mortality among women with sickle-cell disease in France, 1996–2009
2015
Serum Ferritin, Desferrioxamine, and Evolution of HIV-1 Infection in Thalassemic Patients
1998
Sickle cell disease: relation between procoagulant activity of red blood cells from different phenotypes and in vivo blood coagulation activation
1997
Bone disease in children with homozygous β-thalassemia
1990
Genetic polymorphism of the mannose-binding protein gene in children with sickle cell disease: identification of three new variant alleles and relationship to infections
1999
Cerebrovascular accidents in sickle cell disease. Risk factors and blood transfusion influence
1993
Acute clinical events in 299 homozygous sickle cell patients living in France
2000
Does regular blood transfusion prevent progression of cerebrovascular lesions in children with sickle cell disease?
2008
High Titers of Autoantibodies in Patients with Sickle-Cell Disease
2010
Identification of New Prognosis Factors from the Clinical and Epidemiologic Analysis of a Registry of 229 Diamond-Blackfan Anemia Patients
1999
Infectious complications in sickle cell disease are influenced by HLA class II alleles
2002
Glomerular Hyperfiltration in Adult Sickle Cell Anemia
2010
La drépanocytose dans le sud du Zaïre. Étude de deux séries de 251 et 340 malades suivis entre 1988 et 1992
1996
Two novel CD1 E alleles identified in black African individuals
2002
No Evidence for a Defect in Growth Hormone Binding to Liver Membranes in Thalassemia Major*
1989
Recurrent Hematuria in 4 White Patients with Sickle Cell Trait
1984
Diet-responsive proconvertin (factor VII) deficiency inhomocystinuria
1983
Six cases of hereditary spherocytosis revealed by human parvovirus infection
1986
Familial Human Parvovirus Infection Associated with Anemia in Siblings with Heterozygous -Thalassemia
1986
Mössbauer spectroscopy study of iron overloaded livers
1985
Partial splenectomy in sickle cell syndromes.
1991
Fetal haemoglobin variations following hydroxyurea treatment in patients with cyanotic congenital heart disease.
1994
The characterization of protein 4.1 Presles, a shortened variant of RBC membrane protein 4.1
1985
[Treatment of post-transfusion iron overload by deferoxamine].
1989
Calcium Phosphate Metabolism and Bone Disease in Patients with Homozygous Thalassemia
1982
Cutaneous adverse reactions to hydroxyurea in patients with sickle cell disease.
2001
Analysis of crossover type in the ?-3�7 haplotype among sickle cell anemia patients from various parts of Africa
1988
Partial splenectomy in homozygous beta thalassaemia.
1990
Early glomerular dysfunction in patients with sickle cell anemia
1998
Prospective Multicentric Survey On Pulmonary Hypertension (PH) in Adults with Sickle Cell Disease.
2009
Fetal Hemoglobin and F-Cell Responses to Long-Term Hydroxyurea Treatment in Young Sickle Cell Patients
1998
Increased procoagulant activity of red blood cells from patients with homozygous sickle cell disease and beta-thalassemia.
1996
Outcomes of Adult Patients With Sickle Cell Disease Admitted to the ICU
2014
Increased Procoagulant Activity of Red Blood Cells from Patients with Homozygous Sickle Cell Disease and β-Thalassemia
1996
Hematologic Disorders following Prolonged Use of Intravenous Fat Emulsions in Children
1986
Human parvovirus and aplastic crisis in chronic hemolytic anemias: A study of 24 observations
1986
Human parvovirus and thalassaemia
1986
A shortened variant of red cell membrane protein 4.1
1982
Natural History of GBV-C/Hepatitis G Virus Infection Through the Follow-Up of GBV-C/Hepatitis G Virus–Infected Blood Donors and Recipients Studied by RNA Polymerase Chain Reaction and Anti-E2 Serology
1997
Platelet function in sickle cell disease during steady state.
1990